Stocks and Investing
Stocks and Investing
Wed, July 25, 2012
[ 07:42 AM ] - United States, WOPRAI
[ 07:42 AM ] - United States, WOPRAI
[ 07:42 AM ] - United States, WOPRAI
[ 07:42 AM ] - United States, WOPRAI
[ 07:41 AM ] - United States, WOPRAI
[ 07:41 AM ] - United States, WOPRAI
[ 07:41 AM ] - United States, WOPRAI
[ 07:41 AM ] - United States, WOPRAI
[ 07:41 AM ] - United States, WOPRAI
[ 07:41 AM ] - United States, WOPRAI
[ 07:41 AM ] - United States, WOPRAI
[ 07:41 AM ] - United States, WOPRAI
[ 07:41 AM ] - United States, WOPRAI
[ 07:40 AM ] - United States, WOPRAI
[ 06:08 AM ] - United States, Market Wire
[ 06:04 AM ] - United States, Market Wire
[ 04:30 AM ] - United States, Market Wire
[ 04:02 AM ] - United States, WOPRAI
[ 04:02 AM ] - United States, WOPRAI
[ 04:02 AM ] - United States, WOPRAI
[ 04:01 AM ] - United States, WOPRAI
[ 04:01 AM ] - United States, WOPRAI
[ 04:01 AM ] - United States, WOPRAI
[ 04:00 AM ] - United States, WOPRAI
[ 12:12 AM ] - United States, Market Wire
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Matthew Harrison Maintained (BIIB) at Buy with Increased Target to $150 on, Jul 25th, 2012
Matthew Harrison of Morgan Stanley, Maintained "Biogen Inc." (BIIB) at Buy with Increased Target from $140 to $150 on, Jul 25th, 2012.
Matthew has made no other calls on BIIB in the last 4 months.
There are 3 other peers that have a rating on BIIB. Out of the 3 peers that are also analyzing BIIB, 0 agree with Matthew's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Matthew
- Geoffrey Porges of "Leerink Swann" Initiated at Buy on, Monday, July 23rd, 2012
- Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $139 on, Tuesday, May 1st, 2012
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $159 on, Tuesday, May 1st, 2012
Contributing Sources